[go: up one dir, main page]

WO2008019183A3 - Biopolymer and protein production using type iii secretion systems of gram negative bacteria - Google Patents

Biopolymer and protein production using type iii secretion systems of gram negative bacteria Download PDF

Info

Publication number
WO2008019183A3
WO2008019183A3 PCT/US2007/069300 US2007069300W WO2008019183A3 WO 2008019183 A3 WO2008019183 A3 WO 2008019183A3 US 2007069300 W US2007069300 W US 2007069300W WO 2008019183 A3 WO2008019183 A3 WO 2008019183A3
Authority
WO
WIPO (PCT)
Prior art keywords
type iii
negative bacteria
gram negative
biopolymer
iii secretion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/069300
Other languages
French (fr)
Other versions
WO2008019183A2 (en
Inventor
Christopher Ashby Voigt
Daniel Matthew Widmaier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Publication of WO2008019183A2 publication Critical patent/WO2008019183A2/en
Anticipated expiration legal-status Critical
Publication of WO2008019183A3 publication Critical patent/WO2008019183A3/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43586Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from silkworms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Insects & Arthropods (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Proteins, polynucleotide, expression cassette, vector and bacterium compositions for obtaining proteins of interest by expression of same in gram negative bacteria having a Type III secretion system are provided. Uses of the proteins so obtained in the manufacture of isolated proteins, silks, fibers threats, and pharmaceutical compositions are also provided.
PCT/US2007/069300 2006-05-18 2007-05-18 Biopolymer and protein production using type iii secretion systems of gram negative bacteria Ceased WO2008019183A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80175806P 2006-05-18 2006-05-18
US60/801,758 2006-05-18

Publications (2)

Publication Number Publication Date
WO2008019183A2 WO2008019183A2 (en) 2008-02-14
WO2008019183A3 true WO2008019183A3 (en) 2008-12-04

Family

ID=39033539

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/069300 Ceased WO2008019183A2 (en) 2006-05-18 2007-05-18 Biopolymer and protein production using type iii secretion systems of gram negative bacteria

Country Status (1)

Country Link
WO (1) WO2008019183A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015078840A1 (en) * 2013-11-26 2015-06-04 Boehringer Ingelheim International Gmbh Full and partial protein secretion and cell surface display using type iii secretion system
KR102648293B1 (en) * 2014-05-21 2024-03-15 우니페르시테트 바젤 Bacteria-based protein delivery
HRP20211191T1 (en) 2015-11-19 2021-10-29 Universität Basel Virulence attenuated bacteria for treatment of malignant solid tumors
WO2017087827A1 (en) * 2015-11-19 2017-05-26 President And Fellows Of Harvard College Method of making recombinant silk andsilk-amyloid hybrid proteins using bacteria
US12351805B2 (en) 2015-11-19 2025-07-08 Northeastern University Method of making recombinant silk and silk-amyloid hybrid proteins using bacteria
PT3377634T (en) * 2015-11-19 2020-11-16 Univ Basel Bacteria-based protein delivery
CA3046852A1 (en) 2016-12-20 2018-06-28 Universitat Basel Virulence attenuated bacteria based protein delivery
WO2018132821A2 (en) * 2017-01-13 2018-07-19 Bolt Threads, Inc. Elastomeric proteins
WO2019090267A1 (en) * 2017-11-03 2019-05-09 The Regents Of The University Of California Methods and compositions useful for inhibiting growth of certain bacteria
US11178934B2 (en) 2018-07-18 2021-11-23 Bolt Threads Inc. Resilin material footwear and fabrication methods
EP3932937A1 (en) * 2020-07-03 2022-01-05 Universitätsklinikum Hamburg-Eppendorf Novel protein translocation domain
WO2023076924A1 (en) 2021-10-26 2023-05-04 Rensselaer Polytechnic Institute Systems and methods for increased production of recombinant biopolymers via genome engineering and downregulation of basal expression

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DARWIN ET AL.: "The putative invasion proteiin chaperone SicA acts together with InvF to activate the expression of Salmonella typhimurium virulence genes", MOL. MICROBIOL., vol. 35, no. 4, February 2000 (2000-02-01), pages 949 - 960 *
GUZMAN ET AL.: "Direct expression of Bordetella pertussis filamentous hemagglutinin in Escherichia coli and Salmonella typhimurium aroA", INFECT. IMMUN., vol. 59, no. 10, October 1991 (1991-10-01), pages 3787 - 3795 *
WINSTANLEY ET AL.: "Type III secretion systems and pathogenicity islands", J. MED. MICROBIOL., vol. 50, no. 2, February 2001 (2001-02-01), pages 116 - 126, XP002580287 *

Also Published As

Publication number Publication date
WO2008019183A2 (en) 2008-02-14

Similar Documents

Publication Publication Date Title
WO2008019183A3 (en) Biopolymer and protein production using type iii secretion systems of gram negative bacteria
WO2009114702A3 (en) Recombinant production of authentic human proteins using human cell expression systems
WO2010069532A8 (en) Antibodies against human angiopoietin 2
NZ596658A (en) Dig-10 insecticidal cry toxins
AU2011206532A8 (en) Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS)
WO2008073406A3 (en) Solvent tolerant microorganisms
WO2011156380A3 (en) Protein-containing adhesives, and manufacture and use thereof
WO2008021156A3 (en) Antibodies to il-17a
WO2011121289A3 (en) Peptides and their use
WO2006082251A3 (en) Novel hydrophobin fusion products, production and use thereof
WO2008132229A3 (en) Highly concentrated insulin solutions and compositions
EP3564259A3 (en) Recognition tags for tgase-mediated conjugation
MY157798A (en) Ethanol production in non-recombination hosts
EP3162894A3 (en) Methods for the manufacture of proteolytically processed polypeptides
WO2011146891A3 (en) High-affinity fully functional soluble single-domain human cd4, antibodies, and related fusion proteins
WO2011100477A3 (en) Antibodies and processes for preparing the same
WO2008002663A3 (en) Immunogenic protein constructs
WO2011129462A3 (en) A YEAST EXTRACT CONTAINING γ-Glu-X OR γ-Glu-X-Gly AND A METHOD FOR PRODUCING THE SAME
WO2009139930A3 (en) Antibodies and processes for preparing the same
WO2012166665A3 (en) Broad spectrum antibiotics
WO2009102367A3 (en) Tight junction protein modulators and uses thereof
WO2008127664A3 (en) Wheat protein and methods of production
EP2042184A4 (en) Physiologically active polypeptide, polymer micelle having protein enclosed therein, and process for production of the polymer micelle
WO2010128207A3 (en) Product and process for its preparation
WO2016179101A3 (en) Type iii secretion system targeting molecules

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07840188

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07840188

Country of ref document: EP

Kind code of ref document: A2